Reps. Nadler, Cicilline Introduce Bill to Lower Prescription Drug Costs
November 18, 2019
November 18, 2019
WASHINGTON, Nov. 18 -- Rep. Jerrold Nadler, D-New York, chairman of the House Judiciary Committee, issued the following news release:
Today, House Antitrust Subcommittee Chair David N. Cicilline (RI-01) and Judiciary Committee Chairman Jerrold Nadler (NY-10) introduced The Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 (H.R. 5133) to prohibit pharmaceutical companies from engaging in anticompetitive "product hopping." The bill is scheduled . . .
Today, House Antitrust Subcommittee Chair David N. Cicilline (RI-01) and Judiciary Committee Chairman Jerrold Nadler (NY-10) introduced The Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 (H.R. 5133) to prohibit pharmaceutical companies from engaging in anticompetitive "product hopping." The bill is scheduled . . .